We also speculate that since p53 deficiency alone caused tumor development with a relatively short latency (when compared to BCCIP deficiency) it may have masked the opportunity for cells with concurrent p53 and BCCIP loss to develop breast cancer. This evidence concerns the gene TP53 and neoplasm.